Sales Growth YoY (Last Twelve Months): biolifesolutions.com (BLFS)

Brandmark of BioLife Solutions, Inc. (BLFS)

BioLife Solutions, Inc. (BLFS) is implementing AI and robotic lines for product sterilization and packaging. This chart of the rolling 12-month YoY revenue growth demonstrates the adaptability of the business model, where 0.20 reflects the current value of the metric. The issuer serves as a key link in gene therapy supply chains, focusing on high-margin CryoStor media and the development of logistics solutions.

BLFS biolifesolutions.com: Revenue Growth YoY (Last 12 Months) in the range 02/11/2024 - 10/18/2026

Summary analytical data breakdowns for BioLife (BLFS)

- market value and analyst target forecast:
Market Price BioLife|BLFS - Price Target Chart
- company stock exchange capitalization indicators:
Market Value BioLife Corp|BLFS - Real Price to Acquire Entire Company
- business book valuation details:
Book Value per Share BioLife Solutions|BLFS - Company Net Assets|Market Cap to Book Value Multiple biolifesolutions.com|BLFS - Company Total Assets
- company total debt and liquidity indicators:
Total Debt to Capital Coefficient BioLife Solutions, Inc.|BLFS - Long-Term Debt to Equity|Current Liabilities to Capital BioLife Solutions Inc|BLFS - Company Debts|Debt to Book Value Ratio BioLife Solutions Inc|BLFS - Company Long-Term Debt|Short-Term Debt Volume BioLife Solutions|Intermediate Coverage Ratio biolifesolutions.com
- business earnings and investment ratios data:
BLFS - Net Profit|Company Profit Forecast BioLife Solutions, Inc.|BLFS - Price to Earnings Ratio|Price to Future Earnings Ratio BioLife Solutions, Inc.|BLFS - PEG Multiple|Enterprise Value to EBITDA Ratio BioLife Corp|BLFS - Operating profit before deduction of amortization|Net earnings per share for the last four quarters BioLife Solutions|BLFS - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months biolifesolutions.com|BLFS - Earnings per share growth in current year|Net earnings per share growth forecast for next year BioLife Solutions, Inc.
- sales and revenue indicators:
BLFS - Revenue and Sales Volume|Company Expected Revenue BioLife|BLFS - Price-to-Revenue Ratio|Market Cap to Expected Sales Ratio BioLife Solutions, Inc.|BLFS - Sales Growth YoY (TTM)
Analysis of all company metrics:BioLife - BLFS
Signature product of BioLife Corp

BioLife Solutions, Inc. (BLFS) maintains resilience against external shocks by delegating raw material procurement to reliable partners, which minimizes operational risks during scaling. By analyzing the year-over-year sales volume growth trajectory over the TTM, an investor assesses the percentage change in revenue over 12 months to determine the pace of business expansion and timely identify the fading of the asset's primary revenue drivers.

Competitors of BioLife Solutions, Inc. (BLFS)

Annual Revenue Growth (Last Twelve Months) Tempus AI, Inc (TEM)|QGEN: Revenue Growth YoY (Last 12 Months)|Ionis Pharmaceuticals (IONS) - Revenue Growth YoY (Last 12 Months)|Repligen (RGEN) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) Avidity Biosciences, Inc.|Sales Growth YoY (Last Twelve Months) CRISPR Therapeutics|WGS - Revenue Growth Rate YoY (Last Twelve Months)|Sales Growth YoY (TTM) RARE|Revenue Change YoY (Last 12 Months) BEAM|Sales Growth YoY (TTM) SRPT (Sarepta Corp)|TWST - Revenue Growth YoY (Last 12 Months)|TXG: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Intellia Therapeutics|STOK: Sales Growth YoY (TTM)|WVE - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) MAZE|Revenue Growth YoY (Last 12 Months) Sionna Therapeutics, Inc. (SION)|Revenue Growth YoY (Last 12 Months) PRME (Prime Medicine Bio)|Annual Revenue Growth (Last Twelve Months) Taysha|uniQure Pharma - Revenue Growth YoY (Last 12 Months)|MeiraGTx Holdings plc - Sales Growth YoY (Last Twelve Months)|regenxbio.com - Sales Growth YoY (TTM)|Solid Bio (SLDB) - Revenue Growth YoY (Last 12 Months)|OCGN: Sales Growth YoY (TTM)|Revenue Growth YoY (Last 12 Months) Pacific Biosciences of California|BNTC (Benitec Biopharma Inc.) - Sales Growth YoY (TTM)|Sales Growth YoY (Last 12 Months) DSGN (Design Therapeutics)|Sales Growth YoY (TTM) RCKT|Sales Growth YoY (Last Twelve Months) FDMT (4D Molecular Therapeutics Inc)|Sales Growth YoY (TTM) LXEO (Lexeo Therapeutics Inc.)|Revenue Dynamics YoY (Last Twelve Months) KRRO|EDIT - Sales Growth YoY (Last Twelve Months)|Annual Revenue Growth (Last Twelve Months) Silence Therapeutics SLN|ProQR Therapeutics NV (PRQR) - Sales Growth YoY (Last Twelve Months)|Codexis Inc - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Sangamo BioSciences|Sales Growth YoY (Last 12 Months) NAUT (Nautilus Biotechnology)|Sales Growth YoY (Last Twelve Months) metagenomi.co (MGX)|DTIL: Trailing Twelve Months Sales Growth|Sales Growth YoY (Last Twelve Months) Generation Bio Co. GBIO|BOLD: Sales Growth YoY (Last 12 Months)|XCUR: Revenue Growth YoY (Last 12 Months)|Imunon (IMNN) - Revenue Growth YoY (Last 12 Months)|PHIO (RXi Pharmaceuticals) - Revenue Growth YoY (Last 12 Months)|MBIO (Mustang Bio Inc) - Sales Growth YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) TransCode Therapeutics, Inc.|Sales Growth YoY (TTM) bionanogenomics.com|Sales Growth YoY (TTM) APDN|Sales Growth YoY (Last Twelve Months) BLUE (Bluebird Bio)|Sales Growth YoY (Last Twelve Months) ImmunoPrecise Antibodies Ltd. IPA|Revenue Dynamics YoY (Last Twelve Months) OMGA|singulargenomics.com - Sales Growth YoY (TTM)|Regulus Therapeutics Inc. - Revenue Change YoY (Last 12 Months)|SYRS: Sales Growth YoY (TTM)|Sales Growth YoY (Last 12 Months) TBIO|TCON (TRACON Pharmaceuticals) - Sales Growth YoY (TTM)|Sales Growth YoY (Last 12 Months) UBX (unitybiotechnology.com)